Table of Contents Author Guidelines Submit a Manuscript
Journal of Pathogens
Volume 2016, Article ID 4152704, 6 pages
http://dx.doi.org/10.1155/2016/4152704
Research Article

Multidrug Resistant CTX-M-Producing Escherichia coli: A Growing Threat among HIV Patients in India

1Department of Microbiology, Research Laboratory for Oral and Systemic Health, Sree Balaji Dental College and Hospital, BIHER, Bharath University, Chennai 600100, India
2Department of Microbiology, Dr. ALM PGIBMS, University of Madras, Chennai 600113, India
3Government Hospital of Thoracic Medicine, Chennai 600047, India

Received 17 December 2015; Accepted 6 March 2016

Academic Editor: Anand S. Deshmukh

Copyright © 2016 Kesavaram Padmavathy et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Foxman, “The epidemiology of urinary tract infection,” Nature Reviews Urology, vol. 7, no. 12, pp. 653–660, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Lampri, I. Galani, G. Poulakou et al., “Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 10, pp. 2424–2428, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. R. Vignesh, E. M. Shankar, K. G. Murugavel et al., “Urinary infections due to multi-drug-resistant Escherichia coli among persons with HIV disease at a tertiary AIDS Care Centre in south India,” Nephron—Clinical Practice, vol. 110, no. 1, pp. c55–c57, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Padmavathy, K. Padma, and S. Rajasekaran, “Extended-spectrum β-lactamase/AmpC-producing uropathogenic Escherichia coli from HIV patients: do they have a low virulence score?” Journal of Medical Microbiology, vol. 62, no. 3, pp. 345–351, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Nathisuwan, D. S. Burgess, and J. S. Lewis II, “Extended-spectrum β-lactamases: epidemiology, detection, and treatment,” Pharmacotherapy, vol. 21, no. 8, pp. 920–928, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. D. L. Paterson and R. A. Bonomo, “Extended-spectrum β-lactamases: a clinical update,” Clinical Microbiology Reviews, vol. 18, no. 4, pp. 657–686, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. J. D. Pitout and K. B. Laupland, “Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern,” The Lancet Infectious Diseases, vol. 8, no. 3, pp. 159–166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. R. Johnson, J. J. Brown, U. B. Carlino, and T. A. Russo, “Colonization with and acquisition of uropathogenic Escherichia coli as revealed by polymerase chain reaction-based detection,” Journal of Infectious Diseases, vol. 177, no. 4, pp. 1120–1124, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. J. R. Johnson, M. A. Kuskowski, K. Owens, A. Gajewski, and P. L. Winokur, “Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans,” Journal of Infectious Diseases, vol. 188, no. 5, pp. 759–768, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. J.-P. Lavigne, H. Marchandin, J. Delmas et al., “qnrA in CTX-M-producing Escherichia coli isolates from France,” Antimicrobial Agents and Chemotherapy, vol. 50, no. 12, pp. 4224–4228, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Branger, O. Zamfir, S. Geoffroy et al., “Genetic background of Escherichia coli and extended-spectrum β-lactamase type,” Emerging Infectious Diseases, vol. 11, no. 1, pp. 54–61, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Leflon-Guibout, C. Jurand, S. Bonacorsi et al., “Emergence and spread, of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 10, pp. 3736–3742, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Jadhav, A. Hussain, S. Devi et al., “Virulence characteristics and genetic affinities of multiple drug resistant uropathogenic Escherichia coli from a semi urban locality in India,” PLoS ONE, vol. 6, no. 3, Article ID e18063, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Clinical and Laboratory Standards Institute, “Performance standards for antimicrobial susceptibility testing; Twenty third informational supplement,” Tech. Rep. M100:S23, 2013. View at Google Scholar
  15. F.-Y. Chang, L. K. Siu, C.-P. Fung, M.-H. Huang, and M. Ho, “Diversity of SHV and TEM β-lactamases in Klebsiella pneumoniae: gene evolution in Northern Taiwan and two novel β-lactamases, SHV-25 and SHV-26,” Antimicrobial Agents and Chemotherapy, vol. 45, no. 9, pp. 2407–2413, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. P. E. Coudron, “Inhibitor-based methods for detection of plasmid-mediated AmpC β-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis,” Journal of Clinical Microbiology, vol. 43, no. 8, pp. 4163–4167, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Black, E. S. Moland, and K. S. Thomson, “AmpC disk test for detection of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal AmpC β-lactamases,” Journal of Clinical Microbiology, vol. 43, no. 7, pp. 3110–3113, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. O. Clermont, S. Bonacorsi, and E. Bingen, “Rapid and simple determination of the Escherichia coli phylogenetic group,” Applied and Environmental Microbiology, vol. 66, no. 10, pp. 4555–4558, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Le Bouguenec, M. Archambaud, and A. Labigne, “Rapid and specific detection of the pap, afa, and sfa adhesin-encoding operons in uropathogenic Escherichia coli strains by polymerase chain reaction,” Journal of Clinical Microbiology, vol. 30, no. 5, pp. 1189–1193, 1992. View at Google Scholar · View at Scopus
  20. J. R. Johnson and A. L. Stell, “Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise,” Journal of Infectious Diseases, vol. 181, no. 1, pp. 261–272, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Bekal, R. Brousseau, L. Masson, G. Prefontaine, J. Fairbrother, and J. Harel, “Rapid identification of Escherichia coli pathotypes by virulence gene detection with DNA microarrays,” Journal of Clinical Microbiology, vol. 41, no. 5, pp. 2113–2125, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. J. R. Johnson and T. T. O'Bryan, “Detection of the Escherichia coli group 2 polysaccharide capsule synthesis gene kpsM by a rapid and specific PCR-based assay,” Journal of Clinical Microbiology, vol. 42, no. 4, pp. 1773–1776, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Y. Tartof, O. D. Solberg, and L. W. Riley, “Genotypic analyses of uropathogenic Escherichia coli based on fimH single nucleotide polymorphisms (SNPs),” Journal of Medical Microbiology, vol. 56, no. 10, pp. 1363–1369, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Grabe, T. E. Bjerklund-Johansen, H. Botto et al., Guidelines on Urological Infections, European Association of Urology, 2013.
  25. G. H. Talbot, J. Bradley, J. E. Edwards Jr., D. Gilbert, M. Scheid, and J. G. Bartlett, “Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America,” Clinical Infectious Diseases, vol. 42, no. 5, pp. 657–668, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Cantón and T. M. Coque, “The CTX-M β-lactamase pandemic,” Current Opinion in Microbiology, vol. 9, no. 5, pp. 466–475, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. A. L. Paiva, N. Lincopan, K. C. Silva et al., “Low-virulence phylogenetic background of CTX-M-producing Escherichia coli isolated from extraintestinal infections,” Journal of Infection in Developing Countries, vol. 7, no. 10, pp. 756–760, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. T. J. Wiles, R. R. Kulesus, and M. A. Mulvey, “Origins and virulence mechanisms of uropathogenic Escherichia coli,” Experimental and Molecular Pathology, vol. 85, no. 1, pp. 11–19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. D. D. Pitout, K. B. Laupland, D. L. Church, M. L. Menard, and J. R. Johnson, “Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrumβ-lactamases,” Antimicrobial Agents and Chemotherapy, vol. 49, no. 11, pp. 4667–4670, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Bingen-Bidois, O. Clermont, S. Bonacorsi et al., “Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains,” Infection and Immunity, vol. 70, no. 6, pp. 3216–3226, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. J. R. Johnson, S. L. Moseley, P. L. Roberts, and W. E. Stamm, “Aerobactin and other virulence factor genes among strains of Escherichia coli causing urosepsis: association with patient characteristics,” Infection and Immunity, vol. 56, no. 2, pp. 405–412, 1988. View at Google Scholar · View at Scopus
  32. T. Frank, J. R. Mbecko, P. Misatou, and D. Monchy, “Emergence of quinolone resistance among extended-spectrum beta-lactamase-producing Enterobacteriaceae in the Central African Republic: genetic characterization,” BMC Research Notes, vol. 4, article 309, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Prakash, J. S. Lewis II, M. L. Herrera, B. L. Wickes, and J. H. Jorgensen, “Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum β-lactamases,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 3, pp. 1278–1280, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. T. Muratani and T. Matsumoto, “Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae,” International Journal of Antimicrobial Agents, vol. 28, supplement 1, pp. S10–S13, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Baby Padmini, B. A. Raju, and K. R. Mani, “Detection of Enterobacteriaceae producing CTX-M extended spectrum β-lactamases from a tertiary care hospital in south India,” Indian Journal of Medical Microbiology, vol. 26, no. 2, pp. 163–166, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Gupta, T. M. Hooton, P. L. Roberts, and W. E. Stamm, “Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women,” Archives of Internal Medicine, vol. 167, no. 20, pp. 2207–2212, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. K. B. Asha Pai, R. Rai, H. Sanjeev, V. K. Karnaker, and M. S. Krishna Prasad, “Nitrofurantoin: an alternative therapy for uncomplicated cystitis in the era of antimicrobial resistance,” Journal of Clinical and Diagnostic Research, vol. 5, no. 5, pp. 964–966, 2011. View at Google Scholar · View at Scopus
  38. J. Garau, “Other antimicrobials of interest in the era of extended-spectrum β-lactamases: fosfomycin, nitrofurantoin and tigecycline,” Clinical Microbiology and Infection, vol. 14, supplement 1, pp. 198–202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Rodríguez-Baño and A. Pascual, “Clinical significance of extended-spectrum β-lactamases,” Expert Review of Anti-Infective Therapy, vol. 6, no. 5, pp. 671–683, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. D. I. Andersson and D. Hughes, “Antibiotic resistance and its cost: is it possible to reverse resistance?” Nature Reviews Microbiology, vol. 8, no. 4, pp. 260–271, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. R. Cantón and M.-I. Morosini, “Emergence and spread of antibiotic resistance following exposure to antibiotics,” FEMS Microbiology Reviews, vol. 35, no. 5, pp. 977–991, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. C. M. Muvunyi, F. Masaisa, C. Bayingana et al., “Decreased susceptibility to commonly used antimicrobial agents in bacterial pathogens isolated from urinary tract infections in Rwanda: need for new antimicrobial guidelines,” The American Journal of Tropical Medicine and Hygiene, vol. 84, no. 6, pp. 923–928, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. M.-H. Nicolas-Chanoine, J. Blanco, V. Leflon-Guibout et al., “Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15,” Journal of Antimicrobial Chemotherapy, vol. 61, no. 2, pp. 273–281, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. O. Clermont, M. Lavollay, S. Vimont et al., “The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup,” Journal of Antimicrobial Chemotherapy, vol. 61, no. 5, pp. 1024–1028, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. S. H. Lau, M. E. Kaufmann, D. M. Livermore et al., “UK epidemic Escherichia coli strains A-E, with CTX-M-15 β-lactamase, all belong to the international O25:H4-ST131 clone,” Journal of Antimicrobial Chemotherapy, vol. 62, no. 6, pp. 1241–1244, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Hussain, C. Ewers, N. Nandanwar et al., “Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-β-lactamase-producing lineage,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 12, pp. 6358–6365, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Shin and K. S. Ko, “Effect of plasmids harbouring blaCTX-M on the virulence and fitness of Escherichia coli ST131 isolates,” International Journal of Antimicrobial Agents, vol. 46, no. 2, pp. 214–218, 2015. View at Publisher · View at Google Scholar